Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia

Molecular Psychiatry

Volumn 6, Issue 1, 2001, Pages 66-73

  Herken, H ^a   Uz, E ^b   Ozyurt H ^b   Sogut S ^b   Virit, O ^a   Akyol, O ^b  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Catalase (CAT); Free radicals; Glutathione peroxidase (GSH Px); Schizophrenia; Superoxide dismutase (SOD); Thiobarbituric acid reactive substances (TBARS)

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; SCAVENGER; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISORIENTATION; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; OXIDATIVE STRESS; PARANOIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; CATALASE; ERYTHROCYTES; FEMALE; FREE RADICAL SCAVENGERS; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; SCHIZOPHRENIA; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0035133525     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000789     Document Type: Article

References (54)

1. Cytotoxicity and genotoxicity of lipid-oxidation products
2. Superoxide radical: An endogenous toxicant
3. Free radical pathology and antioxidant defense in schizophrenia: A review
4. Diurnal melatonin and cortisol secretion profiles in medicated schizophrenic patients
5. Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia
6. Effects of haloperidol on antioxidant defense system enzymes in schizophrenia
7. The level of lipid peroxidation and the function of the antioxidant system in different forms of schizophrenia
8. Low superoxide dismutase in schizophrenic patients with tardive dyskinesia
9. Impaired antioxidant defense at the onset of psychosis
10. The brief psychiatric rating scale
11. Catalase
12. A simple method for clinical assay of superoxide dismutase
13. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction
14. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein)
15. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase
16. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: Importance of extraction pH and influence of sample preservation and storage
17. Enzymes of the antioxidant defense system in chronic schizophrenic patients
18. Clinical aspects of the dosage of erythrocuprein
19. Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients
20. Normal erythrocyte SOD values in two human diseases: Schizophrenia and cystic fibrosis
21. Glutathione peroxidase and CT scan abnormalities in schizophrenia
22. Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients
23. The effect of chlorpromazine and Li2CO3 on the superoxide dismutase and glutathione peroxidase activities of rat brain, liver and erythrocytes
24. Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: Relation to psychosocial variables
25. Human plasma glutathione peroxidase and symptom severity in schizophrenia
26. Oxygen free radicals and brain dysfunction
27. Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia
28. The preventative role of antioxidants [selegiline and vitamin E] in a rat model of tardive dyskinesia
29. Tardive dyskinesia: Possible involvement of free radicals and treatment with vitamin E
30. The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: An open label study
31. High doses of vitamin E in the treatment of disorders of the central nervous system in the aged
32. Erythrocyte membrane phospholipids in psychotic patients
33. Fatty acid levels in brains of schizophrenics and normal controls
34. Increased turn-over of platelet phosphatidylinositol in schizophrenia
35. Red blood cell membrane dynamics in schizophrenia. I. Membrane fluidity
36. Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition
37. 3H] arachidonic acid into platelet phospholipids of patients with schizophrenia
38. Abnormal incorporation of arachidonic acid into platelets of drug-free patients with schizophrenia
39. Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients
40. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia
41. Fatty acids, cytokines and major depression
42. Alcohol, fatty acids and diet
43. Essential fatty acids and abnormal involuntary movements in the general male population: A study of men born in 1933
44. MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders
45. Increased platelet phospholipase A2 activity in schizophrenia
46. Increased plasma phospholipase-A activity in schizophrenic patients: Reduction after neuroleptic therapy
47. Increased content of immunoreactive prostaglandin E in cerebrospinal fluid of patients with schizophrenia
48. Elevated plasma prostaglandin E2 levels in schizophrenia
49. CSF prostaglandin levels in depressed and schizophrenic patients
50. Cerebrospinal fluid prostaglandin E in depression, mania, and schizophrenia compared to normals
51. Oxidative injury and potential use of antioxidants in schizophrenia
52. Free radicals in brain metabolism and pathology
53. An adjunctive role for ascorbic acid in the treatment of schizophrenia?
54. Antioxidants in the treatment of schizophrenia